Alvogen Group Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
2,800
- Latest Deal Type
-
M&A
- Financing Rounds
-
23
- Investments
-
18
Alvogen Group General Information
Description
Manufacturer of specialty pharmaceutical, generic, and branded products intended for patients around the world. The company offers a broad range of leading molecules for the treatment of conditions in the areas of oncology, cardiology, respiratory, neurology, and gastroenterology, ensuring affordable generic medications that help reduce healthcare costs around the world.
Contact Information
Website
www.alvogen.com(Operating Subsidiary)
Corporate Office
- 44 Whippany Road
- Suite 300
- Morristown, NJ 07960
- United States
Corporate Office
- 44 Whippany Road
- Suite 300
- Morristown, NJ 07960
- United States
Alvogen Group Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Alvogen Group Comparisons
Industry
Financing
Details
Alvogen Group Competitors (40)
One of Alvogen Group’s 40 competitors is Tris Pharma, a Private Debt Financed company based in Monmouth Junction, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Tris Pharma | Private Debt Financed | Monmouth Junction, NJ | ||||
| Alkermes | Formerly VC-backed | Dublin, Ireland | ||||
| Bluefish Pharmaceuticals | Private Equity-Backed | Stockholm, Sweden | ||||
| CMP Pharma | Formerly PE-Backed | Farmville, NC | ||||
| MS Pharma | Private Equity-Backed | Amman, Jordan |
Alvogen Group Patents
Alvogen Group Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3760190-A1 | Controlled-release tablets of pregabalin, method of making, and method of use thereof | Active | 03-Jul-2019 | ||
| EP-3760190-B1 | Controlled-release tablets of pregabalin, method of making, and method of use thereof | Active | 03-Jul-2019 | ||
| US-11974974-B2 | Controlled-release tablets, method of making, and method of use thereof | Active | 03-Jul-2019 | ||
| US-20210000775-A1 | Controlled-release tablets, method of making, and method of use thereof | Active | 03-Jul-2019 | ||
| ES-2953059-T3 | Pregabalin controlled release tablets, method of manufacture, and method of use thereof | Active | 03-Jul-2019 | A61K9/2027 |
Alvogen Group Signals
Alvogen Group Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Alvogen Group Investments & Acquisitions (18)
Alvogen Group’s most recent deal was a PE Growth/Expansion with Alvotech for . The deal was made on 23-Oct-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Alvotech | 23-Oct-2020 | PE Growth/Expansion | Pharmaceuticals | ||
| Assertio Therapeutics (Gralise) | 13-Jan-2020 | Buyout/LBO | Buildings and Property | ||
| Almaject | 01-Jan-2018 | Buyout/LBO | Medical Supplies | ||
| Bittner Pharma | 21-Jul-2017 | Merger/Acquisition | Pharmaceuticals | ||
| County Line Pharmaceuticals | 13-Apr-2016 | Buyout/LBO | Pharmaceuticals |
Alvogen Group Exits (2)
Alvogen Group’s most recent exit was on 23-Oct-2020 from Alvotech. The exit was categorized as with 5 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Alvotech | 23-Oct-2020 | Completed |
|
||
| Labormed Alvogen | 01-Dec-2012 | Merger/Acquisition | Completed |
Alvogen Group Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Almatica Pharma | Morristown, NJ | 2007 | |
| Alvogen Korea | Seoul, South Korea | 1958 | |
| Almaject | Morristown, NJ |
Alvogen Group FAQs
-
When was Alvogen Group founded?
Alvogen Group was founded in 2007.
-
Where is Alvogen Group headquartered?
Alvogen Group is headquartered in Morristown, NJ.
-
What is the size of Alvogen Group?
Alvogen Group has 2,800 total employees.
-
What industry is Alvogen Group in?
Alvogen Group’s primary industry is Drug Discovery.
-
Is Alvogen Group a private or public company?
Alvogen Group is a Private company.
-
What is the current valuation of Alvogen Group?
The current valuation of Alvogen Group is .
-
What is Alvogen Group’s current revenue?
The current revenue for Alvogen Group is .
-
How much funding has Alvogen Group raised over time?
Alvogen Group has raised $2.56B.
-
Who are Alvogen Group’s investors?
AFI Partners, Alvogen Lux Holdings, Athyrium Capital Management, Aztiq Pharma Partners, and Benefit Street Partners are 5 of 12 investors who have invested in Alvogen Group.
-
Who are Alvogen Group’s competitors?
Tris Pharma, Alkermes, Bluefish Pharmaceuticals, CMP Pharma, and MS Pharma are some of the 40 competitors of Alvogen Group.
-
When was Alvogen Group acquired?
Alvogen Group was acquired on 03-Dec-2025.
-
Who acquired Alvogen Group?
Alvogen Group was acquired by Lotus Pharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process